Page last updated: 2024-10-25

dantrolene and Atherosclerotic Parkinsonism

dantrolene has been researched along with Atherosclerotic Parkinsonism in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gómez, EA1
Truong, DD1
Sczesni, B1
Fahn, S1
Gross, J1
Donovan, K1
van Bakel, A1
Wiley, MK1

Other Studies

2 other studies available for dantrolene and Atherosclerotic Parkinsonism

ArticleYear
[Extrapyramidal reactions and neuroleptic malignant syndrome].
    Acta psiquiatrica y psicologica de America latina, 1984, Volume: 30, Issue:4

    Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malign

1984
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Der Nervenarzt, 1988, Volume: 59, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neur

1988